Skip to content

Epigenetic Modifications of Diabetes Mellitus Type I

Epigenetic Modifications Induced by Glycemic Variability

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01623388
Enrollment
0
Registered
2012-06-20
Start date
2013-01-31
Completion date
Unknown
Last updated
2014-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type I Diabetes

Brief summary

This research is being done to find out if significant changes in blood glucose cause bad outcomes in patients with diabetes.

Interventions

PROCEDUREOral glucose tolerance test for Phase I

Oral glucose tolerance test for Diabetic patients in phase I

Sponsors

Scripps Translational Science Institute
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-65 years old * Diagnosis of Type I diabetes * Willing to wear continuous blood glucose monitor as specified in protocol

Exclusion criteria

* Pregnant or planning to become pregnant during the study Healthy control group Inclusion: * 18-65 years old * Willing to wear continuous blood glucose monitor as specified in protocol Exclusion: * Pregnant or planning to become pregnant during the study * Diagnosis of Type I or II Diabetes

Design outcomes

Primary

MeasureTime frame
Evaluate blood sugar variability in Type I diabetics for differences in epigenetic signatures between Type I diabetics with little glycemic variability as compared to those with more pronounced glycemic changes.7 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026